Position in BMY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$8,578,061
+$680,401 QoQ
Shares Held
148,873
+14.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#418
of 2,506 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BENJAMIN EDWARDS INC holds $255,301,186 across 13 Drug Manufacturers - General names. BMY ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
327,322 | $82,367,307 | |
| 2 | JNJ |
Johnson & Johnson
|
160,633 | $40,795,962 | |
| 3 | LLY |
ELI LILLY & Co
|
29,114 | $34,920,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
224,529 | $28,851,976 | |
| 5 | AMGN |
Amgen Inc
|
74,607 | $27,016,686 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
125,525 | $15,858,828 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
148,873 | $8,578,061 | |
| 8 | PFE |
Pfizer Inc
|
237,703 | $5,723,888 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,578,061 | 148,873 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $7,897,660 | 130,217 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $6,214,210 | 115,206 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $5,116,820 | 113,455 | Shares | Defined | 2025-10-23 | |
| 2025-06-30 | $5,186,516 | 112,044 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,094,173 | 116,317 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,555,699 | 115,907 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,962,258 | 115,235 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $14,316 | 264 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $4,925 | 96 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $5,571 | 96 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $293,466 | 4,589 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $318,202 | 4,591 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $273,050 | 3,795 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $249,525 | 3,510 | Shares | Defined | 2022-10-28 | |
| 2022-06-30 | $673,057 | 8,741 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $260,863 | 3,572 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $182,311 | 2,924 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $57,986 | 980 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $39,824 | 596 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $34,784 | 551 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $25,680 | 414 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $24,960 | 414 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $23,755 | 404 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $32,552 | 584 | Shares | Defined | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||